Adhera Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Wake Forest, NC
SEC filing record 1 source field available
Fiscal year end
31 December
Adhera Therapeutics, Inc. has filed 1,210 SEC EDGAR filings since 16 Oct 1995

SEC filing history

Showing 51-75 of 575 matching filings.

Per page
25
Current page
3
NT 10-Q File 000-13789

NT 10-Q filing

Filing date
17 May 2021
Reporting date
31 Mar 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-13789

8-K/A filing

Filing date
11 May 2021
Reporting date
05 May 2021
Next action
Verify source filing
10-K File 000-13789

10-K filing

Filing date
07 Apr 2021
Reporting date
31 Dec 2020
Next action
Verify source filing
NT 10-K File 000-13789

NT 10-K filing

Filing date
01 Apr 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-13789

10-Q filing

Filing date
18 Nov 2020
Reporting date
30 Sep 2020
Next action
Verify source filing
NT 10-Q File 000-13789

NT 10-Q filing

Filing date
16 Nov 2020
Reporting date
30 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-13789

8-K filing

Filing date
05 Nov 2020
Reporting date
05 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-13789

NT 10-Q

Filing date
14 Aug 2020
Reporting date
30 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
20 Jul 2020
Reporting date
07 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-13789

8-K

Filing date
13 Jul 2020
Reporting date
07 Jul 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-13789

8-K

Filing date
30 Jun 2020
Reporting date
26 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-13789

NT 10-Q

Filing date
30 Jun 2020
Reporting date
31 Mar 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-13789

8-K

Filing date
17 Jun 2020
Reporting date
17 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-13789

8-K

Filing date
11 Jun 2020
Reporting date
11 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-13789

8-K

Filing date
11 May 2020
Reporting date
11 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 000-13789

NT 10-K

Filing date
31 Mar 2020
Reporting date
31 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-360856

D filing

Filing date
19 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-13789

8-K filing

Filing date
11 Feb 2020
Reporting date
05 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-13789

8-K filing

Filing date
19 Dec 2019
Reporting date
19 Dec 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .